Among them, the carcinoembryonic antigen (CEA), cytokeratin-19-fragment (CYFRA21-1), pro-gastrin-releasing peptide (ProGRP), and neuron-specific enolase (NSE) are specific tumour markers for the differential diagnosis of lung cancer and have a high diagnostic sensitivity [18, 19]. The gene discussed is ENO2; the disease is lung carcinoma.